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Abstract
Background: Nearly all information processing during cognitive processing takes place during periods of sustained
attention. Sustained attention deficit is among the most commonly reported impairments in bipolar disorder (BP).
The majority of previous studies have only focused on bipolar I disorder (BP I), owing to underdiagnosis or
misdiagnosis of bipolar II disorder (BP II). With the refinement of the bipolar spectrum paradigm, the goal of this
study was to compare the sustained attention of interepisode patients with BP I to those with BP II.
Methods: In all, 51 interepisode BP patients (22 with BP I and 29 with BP II) and 20 healthy controls participated in
this study. The severity of psychiatric symptoms was assessed by the 17-item Hamilton Depression Rating Scale
and the Young Mania Rating Scale. All participants undertook Conners’ Continuous Performance Test II (CPT-II) to
evaluate sustained attention.
Results: After controlling for the severity of symptoms, age and years of education, BP I patients had a significantly
longer reaction times (F(2,68) = 7.648, P = 0.001), worse detectability (d’) values (F(2,68) = 6.313, P = 0.003) and more
commission errors (F(2,68) = 6.182, P = 0.004) than BP II patients and healthy controls. BP II patients and controls
scored significantly higher than BP I patients for d’ (F = 6.313, P = 0.003). No significant difference was found
among the three groups in omission errors and no significant correlations were observed between CPT-II
performance and clinical characteristics in the three groups.
Conclusions: These findings suggested that impairments in sustained attention might be more representative of
BP I than BP II after controlling for the severity of symptoms, age, years of education and reaction time on the
attentional test. A longitudinal follow-up study design with a larger sample size might be needed to provide more
information on chronological sustained attention deficit in BP patients, and to illustrate clearer differentiations
between the three groups.
Introduction
T h ep r e v a l e n c eo fb i p o l a rd i sorder (BP) is estimated at
3.5% to 6.4% of the general population [1,2], and 30% to
50% of those in remission will not achieve premorbid
psychosocial function levels [3]. Accordingly, evidence
has shown that poor functional outcome is highly asso-
ciated with cognitive impairment, and may persist
through the remission period [4].
However, most previous studies only focused on type I
bipolar disorder (BP I) with regard to neuropsychologi-
cal aspects, mainly because type II bipolar disorder
(BP II) was often underdiagnosed or misdiagnosed [5].
Recently, a new bipolar spectrum paradigm has begun
to appear in the research literature and in clinical prac-
tice [6]. The distinctions between BP I and BP II have
been reported in several studies, which indicate that BP
I and BP II are in different diagnostic categories with
regard to genetic [7,8], biological [9], clinical [10,11] and
pharmacological [12] aspects. Therefore, studies that
examine the differences between BP I and BP II should
be given greater attention.
Previous studies have reported that BP I patients may
have cognitive function impairment, and the magnitude
of cognitive dysfunction was greater than that of
patients with BP II, even in the remittance phase [13].
However, some studies have reported that BP II patients
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multiple measures of cognitive function [14,15]. The dis-
crepancy of these studies may be attributed to the inclu-
sion of patients with various levels of disease severity.
Summers et al. [14] did not control for the mood state
of the patients in their study; in particular, manic symp-
toms were not assessed. In the study of Harkavy-Fried-
man et al. [15], the recruited BP participants consisted
of suicide attempters experiencing depressive episodes;
this may have been why their results contradicted other
findings [13,16,17]. We therefore suspect that mood
symptoms might account for the underperformance on
cognitive tests among BP patients.
Sustained attention is a basic requirement for informa-
tion processing. Nearly all aspects of cognitive proces-
sing, such as encoding, storage, planning and problem
solving, take place during periods of sustained attention
[18,19]. Individuals with sustained attention deficits may
be unable to adapt to environmental demands or modify
behaviours, including the inhibition of inappropriate
behaviour [20]. Accordingly, sustained attention deficit
was among the most commonly reported impairments
in BP patients, even for those in remission [21-24].
Therefore, sustained attention deficit may be enduring
and may represent a stable characteristic trait rather
than a temporary state in BP patients [22,25]. Investiga-
tors have inferred that sustained attention deficit might
not be secondary to an acute clinical state, but rather
may constitute a vulnerability marker in the process of
BP [26]. In addition, Clark et al. [27] suggested that sus-
tained attention deficit may also account for cognitive
impairment in other domains [27]. Sustained attention
can be quantified through neuropsychological assess-
ments using continuous performance tests (CPTs). Var-
ious studies have reported a decrease in target
sensitivity during various CPT task performances among
euthymic BP patients. Bora et al. [28] enrolled 71 BP
patients (37 manic patients and 34 euthymic patients)
and 34 healthy controls to illustrate that impaired target
detection and reaction time inconsistencies seemed to
represent trait-related impairments of BP, and that
manic patients had increased commission errors and
vigilance deficits. When assessing a patient’s attention,
CPT-II results may be affected by the possible deleter-
ious effects of disease course, duration of illness and the
number of mood episodes [26,28]. In accord with Bora
et al.’s [28] study, which indicated that sustained atten-
tion and attentional impulsivity might be affected by
mood states, BP patients who were recruited in the pre-
sent study were screened to exclude those who currently
had mood episodes.
To our knowledge, few reports have focused on the
differences between patients with BP I and BP II with
respect to sustained attention. Such a relationship may
further our understanding of sustained attention
between the two bipolar subgroups. The goal of this
s t u d yi st oc o m p a r et h es u s t a ined attention of interepi-
sode patients with BP I or BP II disorder.
Methods
The present study was conducted at National Cheng
Kung University Hospital, Tainan, Taiwan, and was
approved by the Institutional Review Board for the Pro-
tection of Human Subjects. Written informed consent
was obtained from each participant before inclusion into
the study.
Participants
A total of 51 BP patients (22 with BP I and 29 with BP
II) were recruited from the psychiatric outpatient facility
of the National Cheng Kung University Hospital. Each
participant was first interviewed by an attending psy-
chiatrist for an initial evaluation and then interviewed
by a well trained research team member, using the Diag-
nostic and Statistical Manual of Mental Disorders,
fourth edition (DSM-IV) and the validated modified
Chinese version of the Modified Schedule of Affective
Disorder and Schizophrenia - Lifetime (SADS-L), a
semistructured interview based upon DSM-IV criteria to
verify the diagnosis [29-31].
All patients for whom the clinical diagnosis could not
be verified by SADS-L were excluded from the study.
The diagnosis of BP was made according to DSM-IV,
except for BP II, where the 4-day hypomania duration
was replaced by a 2-day criterion. A large number
of empirical data have validated the 2-day duration to
be a more adequate criterion [2,32]. Exclusion criteria
included the presence of any other DSM-IV axis I diag-
nosis, concomitant medical illness, neurological disorder
and/or brain organic conditions, and past history
of diagnosis of illegal substance and alcohol use
disorders.
Patients who scored lower than 10 on the 17-item
Hamilton Depression Rating Scale (HDRS)[33] and the
Young Mania Rating Scale (YMRS)[34] for more than 2
weeks were considered to be in a euthymic state. In this
study, however, all patients had been in a remission
s t a t ef o r1w e e ko rm o r eb e f o r et h e yp a r t i c i p a t e di nt h e
study; therefore, we defined all patients as in the intere-
pisode stage. Clinical variables were collected, such as
diagnosis, illness duration, and symptom ratings.
Additionally, 20 healthy volunteers were recruited as
controls among acquaintances in the community. They
were screened through the SADS-L to exclude partici-
pants with prior psychiatric history. Exclusion criteria
for the controls were significant mental illness, neurolo-
gical disorders, alcohol and drug abuse, and a history of
major mental disorder among first-degree relatives.
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Diagnostic and symptom measurements
The SADS-L is a semistructured interview aimed at for-
mulating the main diagnoses based upon DSM-IV cri-
teria with good inter-rater reliability [29,31]. The 17-
item HDRS is used for assessing the severity of depres-
sion and has gained considerable acceptance within the
international community, including Taiwan [35]; it is
probably the most widely used rating scale for depres-
sion in both practice and research settings. In the pre-
sent study, clinical raters assessed the presence of
symptoms described in the HDRS over the past week.
The YMRS is an 11-item instrument in which a rater
ranks symptoms of mania on 5 explicitly defined grades
of severity. The YMRS yields a score ranging from 0 to
60, with higher scores representing greater psycho-
pathology. The YMRS is a credible assessment of manic
symptoms and is deemed acceptable within the interna-
tional community and Taiwan [36]. In the present
study, clinical raters assessed the presence of symptoms
described in the YMRS over the past week.
Conners’ Continuous Performance Test (CPT-II)
The CPT-II lasts for several minutes to assess the main-
tenance of focused attention. Optimal performance
requires an adequate level of arousal, combined with an
element of executive control to resist distraction and
inhibit responses to stimuli resembling targets [27].
Respondents are required to press the space bar on a
computer keyboard when any letter other than “X”
appears. The interstimulus intervals are 1, 2 and 4 s,
with a display time of 250 ms [37]. Overall, it takes
approximately 14 min to complete the task and all parti-
cipants were given practice tasks prior to the actual
administration of the test. Some variables of sustained
attention measured by CPT-II are described below.
CPT-II produces a standard set of performance mea-
sures, which include the number of errors of omission
and errors of commission. Errors of omission occur
when the participant fails to respond to the target sti-
mulus, whereas errors of commission occur when the
participant responds to a non-target (X) stimulus. Hit
reaction time (hit RT) represents the mean response
time (ms) for all target responses over the full six trial
blocks. Hit reaction time standard error (HRT SE)
represents the consistency of response times and
expresses the standard error response to targets. The
detectability (d’) provides information on how well the
examinee discriminates between targets and non-targets.
According to Lachman’s [38] trade-off effect, signifi-
cant correlations among hit RT, d’ and errors suggests
the occurrence of a trade-off between speed and accu-
racy. Therefore, multivariate analysis of covariance
(MANCOVA) was used to control for the hit RT in
order to compare the CPT-II performance among the
three groups.
Statistical analysis
c
2 analyses were used to test the difference in gender
distribution. The comparisons of age, years of education,
illness duration and clinical symptoms (HDRS and
YMRS scores) were analyzed through multivariate analy-
sis of variance (MANOVA). The Pearson correlation
test was used to test the associations between clinical
variables, demographic variables and CPT-II perfor-
mance. Finally, we conducted MANCOVA with hit RT,
age, years of education and symptoms rating scores as
covariates to compare the CPT-II performance among
BP I patients, BP II patients and healthy controls. All
analyses were performed using SPSS V.13.0 for Win-
dows (SPSS, Chicago, IL, USA).
Results
Clinical and demographic variables
The demographic and clinical characteristics of the
three groups are summarized in Table 1. No significant
differences were found among the three groups for age,
sex distribution and years of education. No difference
was observed between the two BP groups for illness
duration, but severity of symptoms measured by HDRS
and YMRS were significantly higher in BP II than BP I
(Table 1; HDRS: t = 36.91, P < 0.001; YMRS: t = 17.22,
P < 0.001).
After using Pearson correlations to examine the rela-
tionships among all variables of sustained attention and
clinical characteristics, no significant relationships were
observed between CPT-II performance and clinical char-
acteristics. Nevertheless, a significant and negative rela-
tion was shown between years of education and omission
errors in patients with BP I and BP II (r=-0.320,
P < 0.01; Table 2).
Sustained attention variables (CPT performance)
A ss h o w ni nT a b l e3 ,t h eh i tR To fB PIp a t i e n t sw a s
significantly slower than those of BP II and healthy con-
trols (F = 7.648, P = 0.001). The HRT SE of BP II
patients and healthy controls were significantly smaller
than those with BP I (F = 5.252, P = 0.008). After con-
trolling for RT, age, years of education and symptoms
severity, MANCOVA analysis revealed significantly
increased commission errors (F = 6.182, P = 0.004) in
patients of BP I than those with BP II and controls. In
contrast, on target detection (d’), BP II patients and con-
trols scored significantly higher than BP I patients
(F = 6.313, P = 0.003). No significant difference was
found among the three groups on omission errors
(F = 0.313, P = 0.733) (Table 3).
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a significant positive correlation between hit RT and d’
(r = 0.649, P < 0.01). A significant negative correlation
between hit RT and commission errors was also found
(r = -0.661, P < 0.01).
Discussion
The present study revealed that although BP II patients
presented a higher severity for mood symptoms than
BP I, the latter showed a slower hit RT, a greater RT
standard error, more commission errors and a lower d’
than BP II and healthy controls. However, there was
no significant difference among BP I, BP II and healthy
controls on omission errors. Integrating these findings,
it was observed that BP I patients performed worse
than BP II and healthy controls on the CPT-II, had
more impairments in sustained attention (a significant
lower d’, slower hit RT, and greater RT standard error)
and more attentional impulsivity (more commission
errors) than those of BP II and healthy controls. Our
finding contradict those of Najt et al. [39], which illu-
strated that BP II had longer hit RT than BP I,
although only five BP II patients were recruited in
their study.
When accuracy is less than perfect, RT covaries with
the error rate [40,41]. However, most previous studies
that have measured sustained attention among psychia-
tric disorders have tended to neglect reporting RT [42]
and quote the trade-off effect, sacrificing speed for accu-
racy, as indicated by Lachman et al. [38].
Our findings of commission errors in patients with BP
I or BP II contradicted that of previous study results
[15]. However, the task (go/no-go task) used in the pre-
vious study was different from ours, and the authors
centralized the commission error as the only index used
to measure attentional impulsivity regardless of the
trade-off effect, so that hit RT was not incorporated into
the study. The present study accepted the concept of
attentional impulsivity as mentioned in the study by
Swann et al. [43], and incorporated both hit RT and
commission errors as indexes of attentional impulsivity.
As a result, we demonstrated that BP I patients had
higher attentional impulsiveness than BP II patients.
No differences in omission errors between BP I and
BP II were found in this study. Our results suggest
omission errors to be negatively associated with years of
education (r=-0.320, P < 0.01) (Table 2). The possible
reason for the lack of difference in omission errors
between BP I and BP II might be due to a ceiling effect
where the simplicity of the task made for more success-
ful attempts, as no significant difference was found
between the two groups in years of education.
Relations among symptoms, demographic variables and
performance on CPT-II
Previous studies indicated that euthymic BP patients
also demonstrated impairments in attentional perfor-
mance [44,45], which allowed us to investigate the cor-
relations between symptoms and CPT performance. In
the present study, the symptom rating scores on HDRS
and YMRS of BP patients were both 10 or less. No sig-
nificant correlation existed between the symptoms rated
by HDRS or YMRS and CPT-II performance. Our find-
ing was consistent with previous studies that reported
no significant correlations between CPT-II performance
and the score on the YMRS in manic patients [28,45],
or on HDRS in remitted patients [28,46].
Table 1 Demographic and clinical characteristics of the three groups
Control, mean ± SD (N = 20) Bipolar disorder, mean ± SD Analysis
BP I (N = 22) BP II (N = 29) F/c
2 P value
Age 34.00 ± 12.34 34.05 ± 11.91 34.41 ± 12.19 0.009 0.991
HDRS - 4.36 ± 2.73 5.90 ± 2.88 36.91 <0.001
YMRS - 1.86 ± 2.55 3.76 ± 2.66 17.22 <0.001
Illness duration - 10.40 ± 8.80 11.83 ± 11.78 -0.42 0.676
Educational level 14.65 ± 2.35 13.05 ± 2.99 14.45 ± 3.09 2.067 0.134
Male, N (%) 8 (40.0%) 9 (40.9%) 15 (51.7%) 0.88 0.644
BP = bipolar disorder; HDRS = Hamilton Depression Rating Scale; YMRS = Young Mania Rating Scale.
Table 2 Pearson correlation of demographic
characteristics and performance on continuous
performance test (CPT) in patients with bipolar disorder
(BP) types I and II
HDRS YMRS Age Years of education
Omission error 0.119 -0.051 -0.149 -0.320**
Commission error 0.118 0.128 -0.157 0.046
Detection -0.126 -0.150 0.102 -0.001
Hit RT 0.122 -0.013 0.198 -0.191
**P <0 . 0 1 .
HDRS = Hamilton Depression Rating Scale; RT = reaction time; YMRS = Young
Mania Rating Scale.
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education did not affect CPT-II performance [28,46]. In
contrast, our study found a significant correlation
between years of education and CPT-II performance
(Table 2). Moreover, omission errors on the CPT-II are
suggested to be influenced by age [47]. Therefore, in the
statistical analysis, we tried to control for the influence
of years of education and age when determining the dif-
ferences in CPT-II performance between BP I patients
and BP II patients. An explanation for this discrepancy
might be that it is due to the result of a smaller sample
size in the previous study [46]. A significant and nega-
tive relation was shown between years of education and
omission errors in patients with BP I and BP II (r=
-0.320, P < 0.01) (Table 2).
Right prefrontal cortex (PFC) and sustained attention
measured by CPT-II
Functional neuroimaging studies in healthy volunteers
have reported right-lateralized activation in the PFC
during continuous performance tests [48,49]. Human
lesion evidence also supported that the right PFC was
critically involved in sustained attention [50]. The deficit
in sustained attention may provide some insight into the
neurobiological processes involved in bipolar illness.
Accordingly, the different levels of deficit in sustained
attention among BP I, BP II and healthy controls
demonstrated in our study may suggest possible impair-
ments in the right PFC among BP I patients as com-
pared to BP II patients and healthy controls. This would
require further brain imaging studies and other neurop-
sychological testing to examine the relationship.
Limitations
A longitudinal follow-up study might provide more
information on whether the difference of sustained
attention deficit between BP I and BP II is a premorbid
issue or if actual progress is related to mood swings
during the course of the illness. Additionally, a larger
sample size might have illustrated clearer differences
between the three groups.
Most of the patients in the present study were on
medication. However, no evidence indicated any rela-
tionship between medication and CPT-II performance.
While a drug-free or drug-washout cohort would be
desirable, in clinically severe BP patients the medication
is necessary and unavoidable. Remitted patients are
needed to make sure the performance on CPT-II was
not affected by the medication and severity of
symptoms.
To our knowledge, limited studies have focused on the
CPT-II performance of BP II patients especially during
the interepisode state. This study provided the functional
performance of BP II in sustained attention and atten-
tional impulsivity, and revealed differences between BP I
and BP II on CPT-II performance. We made compari-
s o n sa m o n gB PI ,B PI Ia n dh e a l t h yc o n t r o l so nC P T - I I
performance while controlling for reaction time, which
might have confounded the results. In order to prevent
the effect of hospitalization, which may influence CPT-II
performance, no inpatients were recruited in the present
study, reducing the possibility of excess medication or
chronicity that may affect CPT-II performance.
Conclusions
In summary, the present study revealed that BP I
patients performed worse than BP II patients on CPT-II
performance (slower hit RT and greater hit RT standard
error with significantly more commission errors and
worse d’ in patients with BP I). BP I patients had poorer
Table 3 Between-group differences for sustained attention measures
Bipolar disorder (BP), mean ± SD Control, (N = 20) Analysis Bonferroni post hoc test
BP I (N = 22) BP II (N = 29) Mean ± SD F(2,68) P value
Hit RT
a 318.63 ± 16.71 7.648 0.001 A > B, C
HRT SE
a 5.159 ± 0.267 4.070 ± 0.282 4.169 ± 0.383 5.252 0.008 A > B, C
Omission errors
b 1.764 ± 0.552 2.067 ± 0.543 1.212 ± 0.75 0.313 0.733
Commission errors
b 19.490 ± 1.374 14.142 ± 1.351 12.405 ± 1.87 6.182 0.004 A > B, C
d’
b 40.732 ± 7.779 73.825 ± 7.652 77.799 ± 10.57 6.313 0.003 B, C > A
A = BP I; B = BP II; C = control.
aControlling for HDRS, YMRS, educational level and age (MANCOVA).
bControlling for HDRS, YMRS, educational level, age and hit RT (MANCOVA).
d’ = target detection; HDRS = Hamilton Depression Rating Scale; Hit RT = hit reaction time; HRT SE = hit RT standard error; YMRS = Young Mania Rating Scale.
Table 4 Pearson Correlation of indexes of performance
on continuous performance test (CPT) in patients with
bipolar disorder (BP) types I and II
Omission error Commission error Detection
Omission error
Commission error 0.033
Detection 0.026 -0.884**
Hit RT 0.168 -0.661** 0.649**
**P <0 . 0 1 .
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dency of attentional impulsivity than BP II patients.
Further studies using brain imaging techniques are
needed to investigate the difference between the two BP
subtypes on sustained attention performance. Rehabilita-
tion interventions should take into account potential
sustained attention differences between the two bipolar
subtypes, especially in regards to its impact on everyday
functions.
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